Search Results1-6 of  6

  • AIKAWA YUKIHIKO ID: 9000256796788

    Research Laboratories, Toyama Chemical Co., Ltd. (1995 from CiNii)

    Articles in CiNii:1

    • GENERAL PHARMACOLOGY OF T-3761, A NEW ORAL QUINOLONE ANTIBACTERIAL AGENT:(1) EFFECT ON THE CENTRAL NERVOUS SYSTEM (1995)
  • AIKAWA Yukihiko ID: 9000005215574

    Research Laboratories, Toyama Chemical Co., Ltd. (1995 from CiNii)

    Articles in CiNii:2

    • T-614, a Novel Antirheumatic Drug, Inhibits Both the Activity and Induction of Cyclooxygenase-2 (COX-2) in Cultured Fibroblasts (1995)
    • Pharmacological Studies on 3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a Novel Antiinflammatory Agent. 4th Communication : Inhibitory Effect on the Production of Interleukin-1 and Interleukin-6 (1992)
  • AIKAWA Yukihiko ID: 9000253209529

    Articles in CiNii:1

    • Partial purification of gelatinases and effect of anti-inflammatory drugs on the tumor necrosis factor-stimulated production of active gelatinase by granulation tissue in culture. (1989)
  • AIKAWA Yukihiko ID: 9000253210439

    Articles in CiNii:1

    • Pharmacological Studies on 3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a Novel Antiinflammatory Agent. 4th Communication: Inhibitory Effect on the Production of Interleukin-1 and Interleukin-6. (1992)
  • AIKAWA Yukihiko ID: 9000274377238

    富山化学工業(株)綜合研究所 (2008 from CiNii)

    Articles in CiNii:3

    • 関節リウマチ患者ならにアジュバント関節炎ラットの神経, 内分泌, 免疫系に対する精神的ストレス刺激の影響 (2000)
    • GENERAL PHARMACOLOGY OF T-3761, A NEW ORAL QUINOLONE ANTIBACTERIAL AGENT (1) EFFECT ON THE CENTRAL NERVOUS SYSTEM (1995)
    • In Silico創薬技術に基づくStructure-Based Drug Design (SBDD)の実際(セミナー) (2008)
  • Aikawa Yukihiko ID: 9000399166862

    Articles in CiNii:1

    • A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain (2017)
Page Top